Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion description "[Administration of cDNA encoding soluble IFN-gamma receptor (IFN-gamma R)/IgG-Fc fusion proteins, soluble TNF-alpha receptors, or IL-1 receptor antagonist (IL-1ra), protects against either lupus, various forms of arthritis, autoimmune diabetes, or other autoimmune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion evidence source_evidence_literature NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion SIO_000772 11727511 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion wasDerivedFrom befree-2016 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion wasGeneratedBy ECO_0000203 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- befree-2016 importedOn "2016-02-19" NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.